<?xml version="1.0" encoding="UTF-8"?>
<p>The management of deep neck space infections has progressed considerably in the last 100 years. Technological advances have improved diagnostic accuracy and targeted antimicrobial therapy has ensured the role of medical management as a viable treatment option. Human immunodeficiency virus (HIV)-related immunosuppression has been linked to rapidly progressive deep neck space infections (DNSIs) with resultant poor outcomes [
 <xref rid="REF1" ref-type="bibr">1</xref>]. Low immunity in these patients may predispose to a longer recovery period and higher complication rates in comparison to HIV-uninfected individuals.
</p>
